OVERLAND PARK, Kan. — Royal DSM, a global science-based company in nutrition, health and sustainable living, has announced the completion of its acquisition of Erber Group’s Biomin and Romer Labs for an enterprise value of €980 million (approximately $1.1 billion).
The transaction, first announced on June 12, 2020, forecasted enhanced earnings in the first year upon completion, the company said.
Biomin, a specialty animal nutrition and health business, specializes primarily in mycotoxin risk management and gut health performance. The acquisition of Biomin further strengthens DSM’s expertise and reputation as a leading provider of animal health and nutrition. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
